The fact
The pharmaceutical group aims for accelerated growth by 2030 through innovation and acquisitions.
This shift marks a turning point after three months leading the French giant.
2 sources — click a link to read an article on the topic:
The pharmaceutical group aims for accelerated growth by 2030 through innovation and acquisitions.
This shift marks a turning point after three months leading the French giant.